Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bilateral TMJ Arthroscopy and Xeomin for TMJ Disorders
NCT05027243Completed
- Sponsor
- Instituto Português da Face
- Start
- Jan 2016
- Primary completion
- Jun 2021
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Open-label, single-arm trial of botulinum toxin type A in temporomandibular joint disorder (TMJ), sponsored by Instituto Português da Face. Primary endpoint: Pain Visual Analogue Scale at 2.5 years. Started Jan 2016; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
temporomandibular joint disorder (TMJ)
Beyond the preview
Go deeper on NCT05027243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05027243.